EZH2 and small cell lung carcinoma: Therefore, the combined treatment of SAHA and EZH2 inhibitors can induce the senescence of SCLC cells, and inhibit the secretion of SASP, thus inhibiting the proliferation of SCLC cells treated with SAHA.